126 related articles for article (PubMed ID: 26035636)
1. Precise Ratiometric Control of Dual Drugs through a Single Macromolecule for Combination Therapy.
Luo S; Gu Y; Zhang Y; Guo P; Mukerabigwi JF; Liu M; Lei S; Cao Y; He H; Huang X
Mol Pharm; 2015 Jul; 12(7):2318-27. PubMed ID: 26035636
[TBL] [Abstract][Full Text] [Related]
2. Intracellular delivery of mitomycin C with targeted polysaccharide conjugates against multidrug resistance.
Cao Y; Chen D; Zhao P; Liu L; Huang X; Qi C; Liu Y; He H; Wang Q; Liu Y; Chen S
Ann Biomed Eng; 2011 Sep; 39(9):2456-65. PubMed ID: 21701935
[TBL] [Abstract][Full Text] [Related]
3. Intracellular delivery of 10-hydroxycamptothecin with targeted nanostructured lipid carriers against multidrug resistance.
Liu M; Chen D; Mukerabigwi JF; Chen S; Zhang Y; Lei S; Luo S; Wen Z; Cao Y; Huang X; He H
J Drug Target; 2016; 24(5):433-40. PubMed ID: 26422582
[TBL] [Abstract][Full Text] [Related]
4. The effect of spacers in dual drug-polymer conjugates toward combination therapeutic efficacy.
Xu J; Ma M; Mukerabigwi JF; Luo S; Zhang Y; Cao Y; Ning L
Sci Rep; 2021 Nov; 11(1):22116. PubMed ID: 34764340
[TBL] [Abstract][Full Text] [Related]
5. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
Wang L; Wang W; Rui Z; Zhou D
Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
[TBL] [Abstract][Full Text] [Related]
6. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.
Shuhendler AJ; Cheung RY; Manias J; Connor A; Rauth AM; Wu XY
Breast Cancer Res Treat; 2010 Jan; 119(2):255-69. PubMed ID: 19221875
[TBL] [Abstract][Full Text] [Related]
7. Functional Doxorubicin-Loaded Omega-3 Unsaturated Fatty Acids Nanoparticles in Reversing Hepatocellular Carcinoma Multidrug Resistance.
Wang C; Wei X; Shao G
Med Sci Monit; 2021 Feb; 27():e927727. PubMed ID: 33524008
[TBL] [Abstract][Full Text] [Related]
8. Glycyrrhetinic acid-conjugated polymeric prodrug micelles co-delivered with doxorubicin as combination therapy treatment for liver cancer.
Yang T; Lan Y; Cao M; Ma X; Cao A; Sun Y; Yang J; Li L; Liu Y
Colloids Surf B Biointerfaces; 2019 Mar; 175():106-115. PubMed ID: 30529816
[TBL] [Abstract][Full Text] [Related]
9. Synergistic nanoparticulate drug combination overcomes multidrug resistance, increases efficacy, and reduces cardiotoxicity in a nonimmunocompromised breast tumor model.
Shuhendler AJ; Prasad P; Zhang RX; Amini MA; Sun M; Liu PP; Bristow RG; Rauth AM; Wu XY
Mol Pharm; 2014 Aug; 11(8):2659-74. PubMed ID: 24830351
[TBL] [Abstract][Full Text] [Related]
10. Ratiometric co-delivery of multiple chemodrugs in a single nanocarrier.
Chen C; Tao R; Ding D; Kong D; Fan A; Wang Z; Zhao Y
Eur J Pharm Sci; 2017 Sep; 107():16-23. PubMed ID: 28648521
[TBL] [Abstract][Full Text] [Related]
11. Glucose-functionalized multidrug-conjugating nanoparticles based on amphiphilic terpolymer with enhanced anti-tumorous cell cytotoxicity.
Wang J; Yin C; Tang G; Lin X; Wu Q
Int J Pharm; 2013 Jan; 441(1-2):291-8. PubMed ID: 23194888
[TBL] [Abstract][Full Text] [Related]
12. Construction of a biodegradable, versatile nanocarrier for optional combination cancer therapy.
Wen J; Lv Y; Xu Y; Zhang P; Li H; Chen X; Li X; Zhang L; Liu F; Zeng W; Sun S
Acta Biomater; 2019 Jan; 83():359-371. PubMed ID: 30414486
[TBL] [Abstract][Full Text] [Related]
13. Aspirin enhances doxorubicin-induced apoptosis and reduces tumor growth in human hepatocellular carcinoma cells in vitro and in vivo.
Hossain MA; Kim DH; Jang JY; Kang YJ; Yoon JH; Moon JO; Chung HY; Kim GY; Choi YH; Copple BL; Kim ND
Int J Oncol; 2012 May; 40(5):1636-42. PubMed ID: 22322725
[TBL] [Abstract][Full Text] [Related]
14. Tumor-targeted polymeric nanostructured lipid carriers with precise ratiometric control over dual-drug loading for combination therapy in non-small-cell lung cancer.
Liang Y; Tian B; Zhang J; Li K; Wang L; Han J; Wu Z
Int J Nanomedicine; 2017; 12():1699-1715. PubMed ID: 28280336
[TBL] [Abstract][Full Text] [Related]
15. Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy.
Aryal S; Hu CM; Zhang L
Mol Pharm; 2011 Aug; 8(4):1401-7. PubMed ID: 21696189
[TBL] [Abstract][Full Text] [Related]
16. Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram.
Duan X; Xiao J; Yin Q; Zhang Z; Yu H; Mao S; Li Y
ACS Nano; 2013 Jul; 7(7):5858-69. PubMed ID: 23734880
[TBL] [Abstract][Full Text] [Related]
17. Ligand-directed stearic acid grafted chitosan micelles to increase therapeutic efficacy in hepatic cancer.
Yang Y; Yuan SX; Zhao LH; Wang C; Ni JS; Wang ZG; Lin C; Wu MC; Zhou WP
Mol Pharm; 2015 Feb; 12(2):644-52. PubMed ID: 25495890
[TBL] [Abstract][Full Text] [Related]
18. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution.
Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z
J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562
[TBL] [Abstract][Full Text] [Related]
19. Cabozantinib reverses multidrug resistance of human hepatoma HepG2/adr cells by modulating the function of P-glycoprotein.
Xiang QF; Zhang DM; Wang JN; Zhang HW; Zheng ZY; Yu DC; Li YJ; Xu J; Chen YJ; Shang CZ
Liver Int; 2015 Mar; 35(3):1010-23. PubMed ID: 24621440
[TBL] [Abstract][Full Text] [Related]
20. Improved therapeutic effect of DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab')(2) for hepatocellular carcinoma.
Jin C; Qian N; Zhao W; Yang W; Bai L; Wu H; Wang M; Song W; Dou K
Biomacromolecules; 2010 Sep; 11(9):2422-31. PubMed ID: 20831277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
